glp 1 antagonists Top GLP-1 Agonists Balance Weight Loss Efficacy, Safety GLP-1R Antagonist 1 | GLP-1R

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.

Explorethe best bariatric supplements from Barislim for managing your weight

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Learn how this peptide hormone evolved from diabetes research into a personalized precision medicine tool

New trial data for Amgen's GLP-1 drug MariTide shows a weight loss of 20 percent in non-diabetic participants with obesity or overweight.

Learn why weight loss plateaus happen on GLP-1s and how to safely restart progress with expert-backed tips.